|
BIRC6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.91339999966856E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.634600E-04 |
| Normal-vs-Stage2 |
1.377590E-03 |
| Normal-vs-Stage3 |
4.29900000042949E-08 |
| Normal-vs-Stage4 |
2.20939999628911E-08 |
| Stage1-vs-Stage2 |
4.121200E-01 |
| Stage1-vs-Stage3 |
4.401800E-03 |
| Stage1-vs-Stage4 |
2.280500E-03 |
| Stage2-vs-Stage3 |
2.386200E-01 |
| Stage2-vs-Stage4 |
1.253620E-01 |
| Stage3-vs-Stage4 |
5.848000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.5992000003744E-07 |
| Normal-vs-AfricanAmerican |
1.586210E-04 |
| Normal-vs-Asian |
8.216600E-01 |
| Caucasian-vs-AfricanAmerican |
6.856800E-01 |
| Caucasian-vs-Asian |
1.324980E-01 |
| AfricanAmerican-vs-Asian |
1.110770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.69569999947706E-08 |
| Normal-vs-Female |
4.403100E-04 |
| Male-vs-Female |
4.034400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.117580E-03 |
| Normal-vs-Age(41-60Yrs) |
1.429900E-04 |
| Normal-vs-Age(61-80Yrs) |
3.44890000003595E-07 |
| Normal-vs-Age(81-100Yrs) |
2.012500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.135000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.220600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.200200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.235380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.214560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.392800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.070400E-01 |
| Normal-vs-Grade 2 |
8.044700E-04 |
| Normal-vs-Grade 3 |
5.46020000324887E-08 |
| Normal-vs-Grade 4 |
8.7625999789509E-09 |
| Grade 1-vs-Grade 2 |
8.074000E-02 |
| Grade 1-vs-Grade 3 |
4.641900E-03 |
| Grade 1-vs-Grade 4 |
5.616900E-04 |
| Grade 2-vs-Grade 3 |
1.913820E-02 |
| Grade 2-vs-Grade 4 |
1.399060E-03 |
| Grade 3-vs-Grade 4 |
8.904300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.384600E-03 |
| Normal-vs-ccB subtype |
2.48770000044196E-07 |
| ccA subtype-vs-ccB subtype |
1.622230E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.79828999999909E-05 |
| Normal-vs-N1 |
1.482500E-02 |
| N0-vs-N1 |
7.526000E-01 |
|
|
